Clinical Trial Update: Safety and Tolerability of the Vaginal Gel PRO 2000/5 [Phase 1]

View source ↗

Summary

This document reports a Phase 1 clinical trial update on the safety and tolerability of the vaginal gel PRO 2000/5 for HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• PRO 2000/5 vaginal gel

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED